Heeju S. Kim, M.S.

Juvena Therapeutics
Redwood City, California, United States

Disclosure information not submitted.

Presentation(s):

• SUN-045 - Pharmacodynamic Serum Biomarker for JUV-161 - an Insulin-Like Growth Factor 2 Fusion Protein Therapeutic Treatment

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT